Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Down 62%: Is Endocyte a Bad News Buy?
Down 62%: Is Endocyte a Bad News Buy?
Down 62%: Is Endocyte a Bad News Buy?
Submitted by
admin
on May 3, 2014 - 11:18am
Source:
Motley Fool
News Tags:
Endocyte
Headline:
Down 62%: Is Endocyte a Bad News Buy?
Do Not Allow Advertisers to Use My Personal information